Douglas Walter Gaylor - 07 Nov 2025 Form 4 Insider Report for Crexendo, Inc. (CXDO)

Signature
/s/Douglas Walter Gaylor
Issuer symbol
CXDO
Transactions as of
07 Nov 2025
Net transactions value
-$71,740
Form type
4
Filing time
12 Nov 2025, 13:26:30 UTC
Previous filing
28 Oct 2025
Next filing
13 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gaylor Douglas Walter Chief Operating Officer 1225 W WASHINGTON ST, SUITE 213, TEMPE /s/Douglas Walter Gaylor 12 Nov 2025 0001550317

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CXDO Common Stock Options Exercise $22,500 +10,000 +4.1% $2.25 253,135 07 Nov 2025 Direct
transaction CXDO Common stock Sale $71,740 -10,000 -4% $7.17 243,135 10 Nov 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CXDO Stock Options Options Exercise $22,500 -10,000 -31% $2.25 22,000 10 Nov 2025 Common Stock 10,000 $2.25 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a plan intended to comply with Rule 10b5-1(c), previously entered into on December 11, 2024, at which time Mr. Gaylor was not aware of material nonpublic information.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.15 to $7.19. Details can be provided upon request.
F3 The stock options vested over 36 equal monthly installments beginning on 3/12/2019.